BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22888608)

  • 1. Potency testing of veterinary vaccines for animals: the way from in vivo to in vitro. Workshop summary.
    Dev Biol (Basel); 2012; 134():149-52. PubMed ID: 22888608
    [No Abstract]   [Full Text] [Related]  

  • 2. The validation of potency tests: hurdles identified by EMA/CVMP/IWP.
    Woodland R
    Dev Biol (Basel); 2012; 134():69-73. PubMed ID: 22888597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro vaccine potency testing: a proposal for reducing animal use for requalification testing.
    Brown K; Stokes W
    Dev Biol (Basel); 2012; 134():75-81. PubMed ID: 22888598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency testing of veterinary rabies vaccines: replacement of challenge by in vitro testing: considerations for development of alternative assays.
    Lewis CE; Fry AM; Hermann JR; Siev D; Dusek DM; Gatewood DM
    Dev Biol (Basel); 2012; 134():29-33. PubMed ID: 22888592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antigen measurement and potency tests: challenges encountered during method development...and lessons learned.
    Kubiak V
    Dev Biol (Basel); 2012; 134():83-91. PubMed ID: 22888599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards in vitro potency testing of inactivated erysipelas vaccines.
    Balks E; Wolf C; Loessner H; Werner E
    Dev Biol (Basel); 2012; 134():37-44. PubMed ID: 22888593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress and future directions for reduction, refinement, and replacement of animal use in veterinary vaccine potency and safety testing: a report from the 2010 NICEATM-ICCVAM International Vaccine Workshop.
    Stokes WS; Kulpa-Eddy J; Brown K; Srinivas G; McFarland R
    Dev Biol (Basel); 2012; 134():9-21. PubMed ID: 22888590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistency as an alternative to potency testing.
    Duchow K
    Dev Biol (Basel); 2012; 134():119-22. PubMed ID: 22888604
    [No Abstract]   [Full Text] [Related]  

  • 9. Consistency as tool to support in vitro batch potency testing in GMP production.
    Stirling C
    Dev Biol (Basel); 2012; 134():115-8. PubMed ID: 22888603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potency testing of veterinary vaccines: the way from in vivo to in vitro.
    Romberg J; Lang S; Balks E; Kamphuis E; Duchow K; Loos D; Rau H; Motitschke A; Jungbäck C
    Biologicals; 2012 Jan; 40(1):100-6. PubMed ID: 22075457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History, approaches, legal situation and political pressure, outlook, expectations.
    Spieser JM
    Dev Biol (Basel); 2012; 134():3-7. PubMed ID: 22888589
    [No Abstract]   [Full Text] [Related]  

  • 12. Appropriateness of in vitro potency tests as a measure of vaccine or reference stability.
    Pfannenstiel MA; Inman M
    Dev Biol (Basel); 2012; 134():141-8. PubMed ID: 22888607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral safety and extraneous agents testing for veterinary vaccines: rationale for requirements, the European approach.
    Bruckner L
    Biologicals; 2010 May; 38(3):338-9. PubMed ID: 20335051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observer in swine husbandry].
    Boissevain I
    Tijdschr Diergeneeskd; 2009 Jan; 134(1):22-3. PubMed ID: 19256217
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of requirements in the European Union and United States of America for pre-clinical viral safety testing of veterinary vaccines.
    Sheridan S; Coughlin J
    Biologicals; 2010 May; 38(3):340-5. PubMed ID: 20400329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential application of the consistency approach for vaccine potency testing.
    Arciniega J; Sirota LA
    Dev Biol (Basel); 2012; 134():135-9. PubMed ID: 22888606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternatives to in vivo potency and protection tests for veterinary vaccines.
    Lucken RN
    Dev Biol Stand; 1999; 101():67-72. PubMed ID: 10566777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How can the practicing veterinarian select the best vaccine?].
    van Oirschot JT
    Tijdschr Diergeneeskd; 1996 Oct; 121(20):582-5. PubMed ID: 8966705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs.
    De Mattia F; Chapsal JM; Descamps J; Halder M; Jarrett N; Kross I; Mortiaux F; Ponsar C; Redhead K; McKelvie J; Hendriksen C
    Biologicals; 2011 Jan; 39(1):59-65. PubMed ID: 21277791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.